IGEA Pharma N.V. insider transactions
Management transactions
1
Shareholding disclosures
42
First disclosure
22.12.2018
Last disclosure
24.10.2023
Company summary
No management purchase or sale disclosed in the last 90 days.
- Latest purchase
- —
- Net flow 90 d
- CHF 0.00
- Top shareholder
- 25.15%
—
Buys − sales
Negma Group Ltd
This page brings together all IGEA Pharma N.V. (IGEA) insider transactions: 1 management transactions and 42 significant shareholding disclosures published by SIX Exchange Regulation, from 22.12.2018 to 24.10.2023.
Detailed context
This summary provides an overview of the IGEA Pharma N.V. insider transactions and shareholding reports published by SIX Exchange Regulation. To date, there has been 1 management transaction and 42 significant shareholding disclosures recorded, with the latest management transaction occurring on 2023-10-24. Over the last 90 days, there were 0 purchases (CHF 0) and 0 sales (CHF 0) reported. The largest declared shareholders by voting rights are Negma Group Ltd at 25.15%, followed by ATI Biotech SRL at 9.22%, Blue Sky Angel Lab SRL at 9.22%, and C.H.I. B.V at 9.07%.
Insider barometer
90 days
No transaction in this window
Latest transaction
24.10.2023
Largest purchase
—
Largest sale
CHF 56’700
These figures aggregate public disclosures. They are not investment advice.
insider24.ch
Follow IGEA Pharma N.V.’s disclosures
Find new disclosures in your watchlist. With Pro, receive email and Telegram alerts for your chosen companies.
Need more? Discover the Pro plan
IGEA Pharma N.V. insider transactions
Latest shareholding disclosures
IGEA Pharma N.V.
ALL ASSET MANAGEMENT SA · Single shareholder
IGEA Pharma N.V.
GERARDO CARADONNA · Single shareholder
IGEA Pharma N.V.
Canepa Cristina · Single shareholder
IGEA Pharma N.V.
Michele Müller · Single shareholder
IGEA Pharma N.V.
Anna Loraschi · Single shareholder